Fig 1: IL-4 (a, b) and IL-10 (c, d) expression in the sections of LLABCs, using IHC staining, at 400x magnification. Briefly, heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The sections were then incubated with polyclonal Abs to IL-4 (Abcam, ab9622) at a concentration of 4 μg/mL for 30 mins at RT and polyclonal Abs to IL-10 (Abcam, ab34843) at a 1 : 400 dilution for 30 mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualize the staining. The sections were counterstained with haematoxylin. (a, c) Low level of expression; (b, d) high level of expression. The H score (% of positive cells (brown membrane/cytoplasmic-stained tumour and immune cells) × intensity of staining (1 to 3)) was used to assess the level of expression; low was ≤100 and high was >100. Scoring performed on whole tissue section (>10 HPFs); Tu: tumour and Ly: lymphocyte.
Fig 2: Human immune cell infiltration and inflammation in HCV infected HIL mice.Liver sections from (A-B) mock infected or (C-F) HCV infected HIL mice 27 weeks post infection were stained for human CD45 and counterstained with haematoxylin. Representative images showing (A) liver from mock infected HIL mice, (B) high magnification of an area in mock infected mice (Squared region), (C) liver from HCV infected HIL mice, (D-E) high magnification of areas in a hepatocellular adenoma from HCV infected mice, and (F) high magnification of an area in a non-tumour region from HCV infected mice. (G-I) Representative images showing human (G) CD68, (H) CD3 and (I) CD20 stains within hepatocellular adenoma in HCV infected mice. (J-K) Plasma samples at 27–28 weeks post infection were quantified for the presence of human cytokines: (J) IL10, IL12p70, IL17A, IL23 (K) MCP-1, IL6, IL8, IL18 and IFN-γ. Mock n = 10, 106 ffu HCV n = 5, 107 ffu HCV n = 16.
Fig 3: Delayed intraspinal administration of mRNA-LNP encoding hIL-10 improves locomotor function. (A) Open-field locomotor test (BBB) shows significant improvement of hIL-10-treated animals (mRNA-hIL-10 and osm-hIL-10 group) compared with their controls. Asterisks indicate significant difference between the hIL-10-treated animals (mRNA-hIL-10 and osm-hIL-10 group) and SCI and mRNA-GFP groups at various time points. (B) The image shows every position of the measured bones during 1 intact step cycle from the lateral aspect. The step cycle can be divided into stance phase (black) and swing phase (red). (C) The measurement of the rear-view parameters is based on the angle enclosed by a selected bone and the floor plate. The intact value is displayed in blue, while green and red angles represent the deviations followed by contusion injury, respectively. White arrows show the deviations in both directions. (D and E) Kinematic analysis of the animals in the various groups 9 weeks after injury. Note the significantly improved parameters of the hIL-10-treated animals (mRNA-hIL-10 and osm-hIL-10 group) compared with SCI and mRNA-GFP groups. Data represent the mean ± SEM. (A, D, and E) n = 8, biologically independent experiments. *P < 0.05 and indicates significant difference among SCI, mRNA-GFP vs. mRNA-hIL-10 and osm-hIL-10 groups. #P < 0.05 and shows significant difference between SCI, mRNA-GFP vs. mRNA-IL10 group. Data were analyzed using the 2-way ANOVA (A) or 1-way ANOVA with LSD multiple comparisons tests (D and E).
Fig 4: Endometrial expression of IL10, TGFBR1, PTGER2 and PTGER4. Expression of mRNA encoding IL10, TGFBR1, PTGER2 and PTGER4 in endometrial biopsies collected from infertile (closed bar) and fertile animals (open bar), during Periods 1 and 2. RNA was isolated from biopsies, reverse transcribed and analysed by quantitative PCR for the mRNA encoding the anti-inflammatory mediator IL10, and the receptors for the anti-inflammatory mediators transforming growth factor beta 1 (TGFBR1) and prostaglandin E2 (PTGER2 and PTGER4). Numerical values are presented as the mean + SEM.
Fig 5: Ratio of IL1A and IL1B to IL10 expression. Ratio of expression of mRNA encoding IL1A or IL1B to IL10. The relationship between the expression of mRNA encoding IL1A or IL1B to IL10 was determined for infertile (closed bars) and fertile animals (open bars) using numerical values obtained by Q-PCR.
Supplier Page from Abcam for Anti-IL-10 antibody